AbCellera Biologics Inc. Annual Depreciation in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
AbCellera Biologics Inc. quarterly/annual Depreciation history and growth rate from 2019 to 2023.
  • AbCellera Biologics Inc. Depreciation for the quarter ending September 30, 2024 was $3.8M, a 22.6% increase year-over-year.
  • AbCellera Biologics Inc. Depreciation for the twelve months ending September 30, 2024 was $14.2M, a 20.8% increase year-over-year.
  • AbCellera Biologics Inc. annual Depreciation for 2023 was $12.8M, a 42.5% increase from 2022.
  • AbCellera Biologics Inc. annual Depreciation for 2022 was $8.95M, a 103% increase from 2021.
  • AbCellera Biologics Inc. annual Depreciation for 2021 was $4.4M, a 90% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $12.8M +$3.81M +42.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 $8.95M +$4.55M +103% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 $4.4M +$2.09M +90% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $2.32M +$713K +44.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 $1.6M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.